[go: up one dir, main page]

MA38501B1 - Human antibodies to the respiratory syncytial virus protein f and its methods of use - Google Patents

Human antibodies to the respiratory syncytial virus protein f and its methods of use

Info

Publication number
MA38501B1
MA38501B1 MA38501A MA38501A MA38501B1 MA 38501 B1 MA38501 B1 MA 38501B1 MA 38501 A MA38501 A MA 38501A MA 38501 A MA38501 A MA 38501A MA 38501 B1 MA38501 B1 MA 38501B1
Authority
MA
Morocco
Prior art keywords
methods
respiratory syncytial
antibodies
human antibodies
syncytial virus
Prior art date
Application number
MA38501A
Other languages
French (fr)
Other versions
MA38501A1 (en
Inventor
Douglas Macdonald
Xunbao Duan
Anne Gurnett-Bander
David Perez-Caballero
Sumathi Sivapalasingam
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from PCT/US2014/025259 external-priority patent/WO2014159822A2/en
Publication of MA38501A1 publication Critical patent/MA38501A1/en
Publication of MA38501B1 publication Critical patent/MA38501B1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des anticorps entièrement humains qui se lient à une protéine f du virus respiratoire syncytial, des compositions comprenant les anticorps et des procédés d'utilisation. Les anticorps de l'invention sont utiles pour empêcher la fusion du virus avec la membrane cellulaire et empêcher la propagation du virus d'une cellule à l'autre, fournissant ainsi un moyen permettant d'empêcher l'infection, ou de traiter un patient souffrant de l'infection et d'améliorer un ou plusieurs symptômes ou complications associés à l'infection virale. Les anticorps de l'invention peuvent également être utiles pour le diagnostic d'une infection par rsv.The invention relates to fully human antibodies that bind to a respiratory syncytial virus protein, compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for preventing fusion of the virus with the cell membrane and preventing the spread of virus from one cell to another, thereby providing a means for preventing infection, or treating a patient suffering from the infection and to improve one or more symptoms or complications associated with the viral infection. The antibodies of the invention may also be useful for the diagnosis of rsv infection.

MA38501A 2013-03-14 2014-03-13 Human antibodies to the respiratory syncytial virus protein f and its methods of use MA38501B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361782215P 2013-03-14 2013-03-14
PCT/US2014/025259 WO2014159822A2 (en) 2013-03-14 2014-03-13 Human antibodies to respiratory syncytial virus f protein and methods of use thereof

Publications (2)

Publication Number Publication Date
MA38501A1 MA38501A1 (en) 2018-03-30
MA38501B1 true MA38501B1 (en) 2018-11-30

Family

ID=56119088

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38501A MA38501B1 (en) 2013-03-14 2014-03-13 Human antibodies to the respiratory syncytial virus protein f and its methods of use

Country Status (2)

Country Link
AR (1) AR095364A1 (en)
MA (1) MA38501B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115466326B (en) * 2021-06-11 2024-06-04 中国科学院微生物研究所 Humanized monoclonal antibody of respiratory syncytial virus and application thereof

Also Published As

Publication number Publication date
MA38501A1 (en) 2018-03-30
AR095364A1 (en) 2015-10-14

Similar Documents

Publication Publication Date Title
MA40035A (en) PD-L1 ANTIBODY MOLECULES AND THEIR USES
PH12015501558B1 (en) Human antibodies to respiratory syncytial virus f protein and methods of use thereof
MA42622B1 (en) LIAISONS IN TIGIT AND THEIR USES
MA44312A (en) ANTIBODIES AND THEIR METHODS OF USE
MA40041B1 (en) Anti-gitr antibodies and methods of use thereof
MA37945A1 (en) Human antibodies to gfr3 and methods of use thereof
MA45125B1 (en) Anti-alpha-synuclein antibodies and their uses
MA31231B1 (en) Antibodies and anti-robo4 antibodies and their uses.
MA33402B1 (en) Formulations and methods of targeting the complementary c3b antibody
MA39313B1 (en) Anti-egfrviii antibodies and their uses in the treatment of various cancers
MA32566B1 (en) ANTIBODIES THAT NEUTRALIZE HUMAN CYTOMEGALOVIRUSES AND USES THEREOF
MA31225B1 (en) Tie cytomegalovirus for human antibody cells and use.
MA35035B1 (en) POLYPEPTIDE ANTIBODIES THAT ANTAGONIZE CD40
UA104663C2 (en) CD127-BINDING ANTIBODY $CD127-BINDING ANTIBODY
AR058325A1 (en) ANTI MN ANTIBODIES AND METHODS FOR USE
UA109633C2 (en) HUMAN ANTIBODY AGAINST TISSUE FACTOR
MA37538A2 (en) Anti-Ly6 antibodies and immunoconjugates and methods of use
MA38478A1 (en) Human anti-pac1 antibodies
JO2828B1 (en) Anti-Hepcidin Antibodies and Uses Thereof
UA116772C2 (en) SELECTED MONOCLONAL ANTIBODY OR ITS IMMUNOLOGICAL-ACTIVE Fragment Binding to CD47
MA40106A1 (en) Anti-il-25 antibodies and their uses
MA40913A (en) ANTIBODY-DRUG CONJUGATES
WO2006077471A3 (en) Combining therapies targeting multiple toll-like receptors and use thereof
EA202092085A1 (en) THERAPEUTIC ANTIBODIES AGAINST sPLA2-GIB AND THEIR APPLICATION
EA201892071A1 (en) METHOD OF PREVENTION OF THE DISEASE "TRANSPLANTATE AGAINST THE OWNER"